Chin-Wei Wang

Prof. Dr. Chin-Wei Wang

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2016 in Current Osteoporosis Reports
Verified
Journal Article
Closed access
PDF file
CWChin-Wei Wang
Chin-Wei Wang
LMLaurie K. McCauley
Laurie K. McCauley

6 August 2020 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
CWChin-Wei Wang
Chin-Wei Wang
SASajjad Ashnagar
Sajjad Ashnagar
RGRiccardo Di Gianfilippo
Riccardo Di Gianfilippo
MAMichelle Arnett
Michelle Arnett
JKJanet Kinney
Janet Kinney
Hom-Lay WangHom-Lay Wang
Hom-Lay Wang

8 May 2020 in Journal of Dental Research
Verified
Journal Article
Open access
PDF file
CWChin-Wei Wang
Chin-Wei Wang
SYS.H. Yu
S.H. Yu
TFT. Fretwurst
T. Fretwurst
LLL. Larsson
L. Larsson
JSJ.V. Sugai
J.V. Sugai
WGW.V. Giannobile
W.V. Giannobile
Tooth extraction results in alveolar bone resorption and is accompanied by postoperative swelling and pain. Maresin 1 (MaR1) is a proresolving lipid mediator produced by macrophages during the resolution phase of inflammation, bridging healing and tissue regeneration. The aim of this study was to examine the effects of MaR1 on tooth extraction socket wound healing in a preclinical rat model. The maxillary right first molars of Sprague-Dawley rats were extracted, and gelatin scaffolds were placed into the sockets with or without MaR1. Topical application was also given twice a week until complete socket wound closure up to 14 d. Immediate postoperative pain was assessed by 3 scores. Histology and microcomputed tomography were used to assess socket bone fill and alveolar ridge dimensional changes at selected dates. The assessments of coded specimens were performed by masked, calibrated examiners. Local application of MaR1 potently accelerated extraction socket healing. Macroscopic and histologic analysis revealed a reduced soft tissue wound opening and more rapid re-epithelialization with MaR1 delivery versus vehicle on socket healing. Under micro–computed tomography analysis, MaR1 (especially at 0.05 μg/μL) stimulated greater socket bone fill at day 10 as compared with the vehicle-treated animals, resulting in less buccal plate resorption and a wider alveolar ridge by day 21. Interestingly, an increased ratio of CD206+:CD68+ macrophages was identified in the sockets with MaR1 application under immunohistochemistry and immunofluorescence analysis. As compared with the vehicle therapy, local delivery of MaR1 reduced immediate postoperative surrogate pain score panels. In summary, MaR1 accelerated extraction wound healing, promoted socket bone fill, preserved alveolar ridge bone, and reduced postoperative pain in vivo with a rodent preclinical model. Local administration of MaR1 offers clinical potential to accelerate extraction socket wound healing for more predictable dental implant reconstruction.

Verified
Journal Article
Open access
PDF file
WLWen Chun Liu
Wen Chun Liu
YYYu-Hsin Yang
Yu-Hsin Yang
YWYu-Chin Wang
Yu-Chin Wang
WCWei-Min Chang
Wei-Min Chang
CWChin-Wei Wang
Chin-Wei Wang
Maresins are lipid mediators derived from omega-3 fatty acids with anti-inflammatory and pro-resolving properties, capable of promoting tissue regeneration and potentially serving as a therapeutic agent for chronic inflammatory diseases. The aim of this review was to systematically investigate preclinical and clinical studies on maresin to inform translational research. Two independent reviewers performed comprehensive searches with the term “Maresin (NOT) Review” on PubMed. A total of 137 studies were included and categorized into 11 human organ systems. Data pertinent to clinical translation were specifically extracted, including delivery methods, optimal dose response, and specific functional efficacy. Maresins generally exhibit efficacy in treating inflammatory diseases, attenuating inflammation, protecting organs, and promoting tissue regeneration, mostly in rodent preclinical models. The nervous system has the highest number of original studies (n = 25), followed by the cardiovascular system, digestive system, and respiratory system, each having the second highest number of studies (n = 18) in the field. Most studies considered systemic delivery with an optimal dose response for mouse animal models ranging from 4 to 25 μg/kg or 2 to 200 ng via intraperitoneal or intravenous injection respectively, whereas human in vitro studies ranged between 1 and 10 nM. Although there has been no human interventional clinical trial yet, the levels of MaR1 in human tissue fluid can potentially serve as biomarkers, including salivary samples for predicting the occurrence of cardiovascular diseases and periodontal diseases; plasma and synovial fluid levels of MaR1 can be associated with treatment response and defining pathotypes of rheumatoid arthritis. Maresins exhibit great potency in resolving disease inflammation and bridging tissue regeneration in preclinical models, and future translational development is warranted.

23 March 2022 in Clinical Implant Dentistry and Related Research
Verified
Journal Article
Closed access
ARAndrea Ravidà
Andrea Ravidà
RSRafael Siqueira
Rafael Siqueira
RGRiccardo Di Gianfilippo
Riccardo Di Gianfilippo
GKGurpreet Kaur
Gurpreet Kaur
AGAnthony Giannobile
Anthony Giannobile
Hom-Lay WangHom-Lay Wang
Hom-Lay Wang

20 February 2020 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
IWI-Ching Wang
I-Ching Wang
HAHoussam Askar
Houssam Askar
IGIya Ghassib
Iya Ghassib
CWChin-Wei Wang
Chin-Wei Wang
Hom-Lay WangHom-Lay Wang
Hom-Lay Wang